Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reda Alhajj

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Cancers|April 13, 2024
Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate CancerYaser Gamallat, Joema Felipe Lima, Sima Seyedi, et al.
Cancers|June 22, 2023
Serrate RNA Effector Molecule (SRRT) Is Associated with Prostate Cancer Progression and Is a Predictor of Poor Prognosis in Lethal Prostate CancerYaser Gamallat, Muhammad Choudhry, Qiaowang Li, et al.
BJU International|September 7, 2013
Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcomeTarek A Bismar, Mohammed Alshalalfa, Lars F Petersen, et al.
Molecular Biology Reports|February 25, 2016
microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patientsAshraf Bakkar, Mohammed Alshalalfa, Lars F Petersen, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Cancers|April 13, 2024
Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate CancerYaser Gamallat, Joema Felipe Lima, Sima Seyedi, et al.
Cancers|June 22, 2023
Serrate RNA Effector Molecule (SRRT) Is Associated with Prostate Cancer Progression and Is a Predictor of Poor Prognosis in Lethal Prostate CancerYaser Gamallat, Muhammad Choudhry, Qiaowang Li, et al.
BJU International|September 7, 2013
Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcomeTarek A Bismar, Mohammed Alshalalfa, Lars F Petersen, et al.
Molecular Biology Reports|February 25, 2016
microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patientsAshraf Bakkar, Mohammed Alshalalfa, Lars F Petersen, et al.
Pageof 9